Denali Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | |
| – | – | – | – | – | 51.3% | 3,247.9% | 3,163.5% | 2,537.3% | 31.8% | 889.5% | 1,236.2% | 386.2% | 1,103.4% | 1,415.5% | 909.0% | 571.7% | 17.3% | 759.9% | 286.5% | 1,354.0% | 542.4% | 204.3% | 176.7% | 2,466.6% | 895.8% | 366.6% | 5.2% | 7,082.6% | – | – | – | – | – | – | – | – | – | – | 2.6% | 2,989.8% | |
| – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | 97.4% | -2,889.8% | |
| – | – | – | – | – | 12.7% | 3,247.9% | 3,163.5% | 2,537.3% | 31.8% | 889.5% | 1,236.2% | 386.2% | 1,103.4% | 1,415.5% | 909.0% | 571.7% | 17.3% | 759.9% | 286.5% | 1,354.0% | 542.4% | 204.3% | 176.7% | 2,466.6% | 895.8% | 366.6% | 33.2% | 7,082.6% | – | – | – | – | – | – | – | – | – | – | 2,692.0% | 11,118.8% | |
| – | – | – | – | – | 3.5% | 869.0% | 418.4% | 739.6% | 8.8% | 221.4% | 359.2% | 82.4% | 232.9% | 348.4% | 239.0% | 168.3% | 5.7% | 239.0% | 83.0% | 365.5% | 173.9% | 53.5% | 40.3% | 653.5% | 228.7% | 77.2% | 8.9% | 1,998.8% | – | – | – | – | – | – | – | – | – | – | 1,006.7% | 4,016.0% | |
| – | – | – | – | – | 16.2% | 4,116.8% | 3,581.9% | 3,276.9% | 40.5% | 1,110.9% | 1,595.4% | 468.7% | 1,336.3% | 1,763.9% | 1,148.0% | 740.0% | 23.0% | 998.9% | 369.5% | 1,719.5% | 716.3% | 257.8% | 217.0% | 3,120.1% | 1,124.4% | 443.8% | 42.0% | 9,081.5% | – | – | – | – | – | – | – | – | – | – | 3,719.5% | 14,997.1% | |
| – | – | – | – | – | -16.2% | -4,016.8% | -3,481.9% | -3,176.9% | 59.5% | -1,010.9% | -1,495.4% | -368.7% | -1,236.3% | -1,663.9% | -1,048.0% | -640.0% | 77.0% | -898.9% | -269.5% | -1,619.5% | -616.3% | -157.8% | -117.0% | -3,020.1% | -1,024.4% | -343.8% | 58.0% | -8,981.5% | – | – | – | – | – | – | – | – | – | – | -3,622.1% | -15,058.2% | |
| – | – | – | – | – | 0.0% | 0.0% | 957.0% | 1,319.7% | 12.5% | 375.1% | 57.4% | 17.7% | 325.7% | 85.2% | 44.4% | 20.7% | 0.5% | 14.9% | 4.9% | 19.0% | 10.3% | 3.0% | 5.0% | 117.6% | 64.8% | 60.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -15.8% | -3,693.9% | -3,320.6% | -2,959.9% | 61.7% | -927.3% | -1,397.4% | -340.9% | -1,154.8% | -1,578.7% | -1,003.6% | -619.3% | 77.6% | -884.0% | -264.6% | -1,600.5% | -606.0% | -154.8% | -112.0% | -2,902.5% | -959.7% | -312.4% | 62.3% | -7,841.6% | – | – | – | – | – | – | – | – | – | – | -3,539.2% | -14,188.4% | |
| – | – | – | – | – | -0.6% | 0.0% | -49.0% | 0.0% | -1.9% | – | -7.5% | -0.8% | 1.6% | -3.7% | 1.4% | 0.6% | 0.3% | -26.6% | 3.2% | 14.8% | -4.6% | -3.0% | 0.1% | 59.4% | -0.1% | -28.6% | -0.8% | 178.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -15.8% | -3,693.9% | -3,320.6% | -2,959.9% | 61.7% | -927.3% | -1,390.0% | -340.0% | -1,156.4% | -1,575.0% | -1,004.9% | -619.9% | 77.3% | -884.0% | -264.6% | -1,600.5% | -601.4% | -154.8% | -112.0% | -2,902.5% | -959.6% | -312.4% | 62.3% | -7,841.6% | – | – | – | – | – | – | – | – | – | – | -3,539.2% | -14,191.2% | |
| – | – | – | – | – | -16.2% | -3,883.6% | -3,369.4% | -2,982.2% | 61.3% | -953.7% | -1,456.3% | -354.8% | -1,192.3% | -1,605.4% | -1,011.3% | -617.1% | 77.7% | -872.3% | -255.0% | -1,559.1% | -589.3% | -149.8% | -108.0% | -2,842.3% | -919.9% | -283.8% | 63.1% | -7,666.6% | – | – | – | – | – | – | – | – | – | – | -3,440.2% | -13,798.3% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.